Management of Patients With Febrile Neutropenia: A Teachable Moment

JAMA Intern Med. 2018 Apr 1;178(4):558-559. doi: 10.1001/jamainternmed.2017.8386.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Acute Kidney Injury / chemically induced*
  • Administration, Intravenous
  • Administration, Oral
  • Adult
  • Amoxicillin-Potassium Clavulanate Combination / therapeutic use
  • Anti-Bacterial Agents / adverse effects*
  • Anti-Bacterial Agents / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology
  • Chemotherapy, Adjuvant
  • Chemotherapy-Induced Febrile Neutropenia / drug therapy*
  • Cyclophosphamide / administration & dosage
  • Doxorubicin / administration & dosage
  • Female
  • Fluoroquinolones / therapeutic use
  • Hospitalization
  • Humans
  • Medical Overuse*
  • Neoplasm Staging
  • Piperacillin, Tazobactam Drug Combination / adverse effects*
  • Piperacillin, Tazobactam Drug Combination / therapeutic use
  • Risk Assessment
  • Vancomycin / adverse effects*
  • Vancomycin / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Fluoroquinolones
  • Piperacillin, Tazobactam Drug Combination
  • Vancomycin
  • Amoxicillin-Potassium Clavulanate Combination
  • Doxorubicin
  • Cyclophosphamide